Banner
Share

Our Expertise

CHAM_Rheumatology_Group_2013_10-11

Complicated rheumatologic disease requires careful evaluation and thoughtful, customized treatment. Our team of experts in the Division of Rheumatology at the Children's Hospital at Montefiore (CHAM) understand the complexity of these rheumatologic diseases.

Our specialists are among the best in the country, leading in groundbreaking research to create new therapies that have revolutionized children’s rheumatologic treatment. As experts in childhood medicine and rheumatology—the study of joints and autoimmune disease—our goal is to meet the complex needs of our patients and their families. We work with a child psychologist, psychiatrist and a social worker to integrate services and counseling for our patients and their families. Treatment and therapies for children can be demanding, so we offer a variety of support services, including:
 
• Family counseling
• Social services
• Support groups
• The Susan Pincus Family Learning Place, a multimedia pediatric health information and resource center
 
We welcome input from our patients and their families, giving all a say in their care. This collaborative approach to manage the condition helps create the right treatment program for each of our patients.
 

OUR TEAM

Norman Ilowite, MD

We are leveraging our clinical and investigative resources to develop treatment options for devastating conditions such as juvenile idiopathic arthritis (JIA).

Norman Ilowite, MD

Chief, Division of Rheumatology
Professor, Pediatrics, Albert Einstein College of Medicine

SERVICES & PROGRAMS

Receiving care at our facilities gives your child a huge advantage. Our pediatric rheumatologists are trained in both childhood medicine and rheumatology with access to state-of-the-art facilities and the latest clinical trials. Using a multidisciplinary approach to treatment and therapies, our pediatric rheumatologists work with more than 100 different pediatric specialists under one roof. We coordinate services and consultations with a variety of subspecialties such as:

  • Ophthalmology
  • Orthopaedics
  • Gastroenterology and Nutrition
  • Neurology
  • Infectious Disease
  • Nephrology
  • Physical Medicine Rehabilitation
  • Dermatology
  • Hematology and Stem Cell Transplant
  • Childhood Development
  • Lupus Nephritis

Children have different needs than their adult counterparts and these conditions can have a major effect on their development, influencing educational, emotional and social requirements. 

Our specialists have expansive experience treating thousands of children with rheumatologic diseases, such as: 

• Juvenile idiopathic arthritis (formerly known as juvenile rheumatoid arthritis, or JRA 
• Lupus  (also called systemic lupus erythematosus)
• Juvenile dermatomyositis 
• Scleroderma 
• Fibromyalgia 
• Raynaud's phenomenon 
• Henoch-Schonlein purpura 
• Advanced Lyme disease
• Sjogren's syndrome 
• Other childhood autoimmune and connective tissue disorders.

We have a monthly multidisciplinary lupus nephritis clinic with the Nephrology Division.  Our facilities include a state of the art infusion center for patients who need intravenous infusions.

Education & Training

CHAM_MSHP_PS28_CHAMJAM_2012_04_029_316x210.jpgThe Pediatric Rheumatology fellowship at CHAM and Albert Einstein College of Medicine is a three-year program with the goal of training physicians to become leaders in pediatric rheumatology. Candidates are selected on the basis of excellence during their pediatrics training and medical school. Previous research experience is encouraged but not required for application to the program.

 





LEARN ABOUT OUR FELLOWSHIP PROGRAM

RESEARCH

MMG_Castle_Hill_2013_05-415_316x210.jpg

The Rheumatology Department at CHAM is a national leader in children’s rheumatologic care and research.  
Our research focuses on novel therapies for children with  chronic arthritis and systemic juvenile idiopathic arthritis. We also concentrate on atherosclerosis prevention in pediatric systemic lupus erythematosus and nonpharmacologic treatment of pain in childhood rheumatologic conditions. Our groundbreaking studies have helped to create new therapies that are revolutionizing the treatment of children and adolescents suffering from rheumatologic diseases and disorders.






FIND A CLINICAL TRIAL